Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Abbott Laboratories stacks up to the competition and put relevant competitor and industry information at your fingertips.
EAS, Ensure, Similac, ZonePerfect
Abbott Laboratories is a public company headquartered in Illinois with an estimated 115,000 employees. In the US, the company has a notable market share in at least six industries: Medical Device Manufacturing, Drug & Alcohol Test Kit Manufacturing, Glucose Meter Manufacturing, Meal Replacement Product Manufacturing, Infant Formula Manufacturing, Toxicology Laboratories and Drug & Alcohol Test Kit Manufacturing. Their largest market share is in the Infant Formula Manufacturing industry, where they account for an estimated 58.6% of total industry revenue and are considered an All Star because they display stronger market share, profit and revenue growth compared to their peers.
Of the 3 core revenue-generating products and services in the Infant Formula Manufacturing industry, Abbott Laboratories offers:
Of the 6 core revenue-generating products and services in the Toxicology Laboratories industry, Abbott Laboratories offers:
Of the 12 core revenue-generating products and services in the Medical Device Manufacturing industry, Abbott Laboratories offers:
Of the 3 core revenue-generating products and services in the Meal Replacement Product Manufacturing industry, Abbott Laboratories offers:
Strengths and weaknesses take into account internal factors, and are based on Abbott Laboratories's performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Infant Formula Manufacturing , Toxicology Laboratories , Medical Device Manufacturing , Meal Replacement Product Manufacturing , Glucose Meter Manufacturing , Drug & Alcohol Test Kit Manufacturing industries
Gain strategic insight and analysis on 700+ in the United States industries
(& thousands of global industries)
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Revenue | 30,578.0 | 31,904.0 | 34,608.0 | 43,075.0 | 43,653.0 | 40,109.0 |
Cost of Revenue | ||||||
Cost of Revenue, Non-Cash | ||||||
Gross Profit | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Cash and Equivalents | 3,844.0 | 3,860.0 | 6,838.0 | 9,799.0 | 9,882.0 | 6,896.0 |
Short-Term Investments | ||||||
Derivative Assets, Current | ||||||
Restricted Cash and Investments | ||||||
00000 |
BALANCE DATE | 12/31/2018 | 12/31/2019 | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2023 |
---|---|---|---|---|---|---|
Net Income | 2,368.0 | 3,687.0 | 4,495.0 | 7,071.0 | N/A | N/A |
Income (Loss) From Discontinued Operations | ||||||
Depreciation, Depletion and Amortization | ||||||
Amortization of Financing Costs and Discounts | ||||||
00000 |
IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.